These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8677295)

  • 1. Incidence of salivary gland tumors among atomic bomb survivors, 1950-1987. Evaluation of radiation-related risk.
    Land CE; Saku T; Hayashi Y; Takahara O; Matsuura H; Tokuoka S; Tokunaga M; Mabuchi K
    Radiat Res; 1996 Jul; 146(1):28-36. PubMed ID: 8677295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salivary gland tumors among atomic bomb survivors, 1950-1987.
    Saku T; Hayashi Y; Takahara O; Matsuura H; Tokunaga M; Tokunaga M; Tokuoka S; Soda M; Mabuchi K; Land CE
    Cancer; 1997 Apr; 79(8):1465-75. PubMed ID: 9118025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer incidence in atomic bomb survivors. Part II: Solid tumors, 1958-1987.
    Thompson DE; Mabuchi K; Ron E; Soda M; Tokunaga M; Ochikubo S; Sugimoto S; Ikeda T; Terasaki M; Izumi S
    Radiat Res; 1994 Feb; 137(2 Suppl):S17-67. PubMed ID: 8127952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer and non-cancer effects in Japanese atomic bomb survivors.
    Little MP
    J Radiol Prot; 2009 Jun; 29(2A):A43-59. PubMed ID: 19454804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the risks of cancer incidence and mortality following radiation therapy for benign and malignant disease with the cancer risks observed in the Japanese A-bomb survivors.
    Little MP
    Int J Radiat Biol; 2001 Apr; 77(4):431-64. PubMed ID: 11304437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer incidence in atomic bomb survivors. Part IV: Comparison of cancer incidence and mortality.
    Ron E; Preston DL; Mabuchi K; Thompson DE; Soda M
    Radiat Res; 1994 Feb; 137(2 Suppl):S98-112. PubMed ID: 8127954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for primary breast cancer in Japan: 8-year follow-up of atomic bomb survivors.
    Goodman MT; Cologne JB; Moriwaki H; Vaeth M; Mabuchi K
    Prev Med; 1997; 26(1):144-53. PubMed ID: 9010910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies of the mortality of A-bomb survivors, report 7. Part III. incidence of cancer in 1959-1978, based on the tumor registry, Nagasaki.
    Wakabayashi T; Kato H; Ikeda T; Schull WJ
    Radiat Res; 1983 Jan; 93(1):112-46. PubMed ID: 6823504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gamma radiation sensitivity and risk of malignant and benign salivary gland tumors: a pilot case-control analysis.
    Zheng R; Wang LE; Bondy ML; Wei Q; Sturgis EM
    Cancer; 2004 Feb; 100(3):561-7. PubMed ID: 14745873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salivary gland tumors after childhood radiation treatment for benign conditions of the head and neck: dose-response relationships.
    Schneider AB; Lubin J; Ron E; Abrahams C; Stovall M; Goel A; Shore-Freedman E; Gierlowski TC
    Radiat Res; 1998 Jun; 149(6):625-30. PubMed ID: 9611101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignant and benign ovarian neoplasms among atomic bomb survivors, Hiroshima and Nagasaki, 1950-80.
    Tokuoka S; Kawai K; Shimizu Y; Inai K; Ohe K; Fujikura T; Kato H
    J Natl Cancer Inst; 1987 Jul; 79(1):47-57. PubMed ID: 3474449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer incidence in atomic bomb survivors. Part III. Leukemia, lymphoma and multiple myeloma, 1950-1987.
    Preston DL; Kusumi S; Tomonaga M; Izumi S; Ron E; Kuramoto A; Kamada N; Dohy H; Matsuo T; Matsui T [corrected to Matsuo T]
    Radiat Res; 1994 Feb; 137(2 Suppl):S68-97. PubMed ID: 8127953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding estimation of time and age effect-modification of radiation-induced cancer risks among atomic-bomb survivors.
    Lagarde F
    Health Phys; 2006 Dec; 91(6):608-18. PubMed ID: 17099404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Profiles of non-cancer diseases in atomic bomb survivors.
    Kodama K; Fujiwara S; Yamada M; Kasagi F; Shimizu Y; Shigematsu I
    World Health Stat Q; 1996; 49(1):7-16. PubMed ID: 8896251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comment on "Incidence of salivary gland tumors among atomic bomb survivors, 1950-1987. Evaluation of radiation-related risk" by Land et al. (Radiat. Res. 146, 28-36, 1996).
    Pogoda JM; Preston-Martin S
    Radiat Res; 1996 Sep; 146(3):356. PubMed ID: 8752317
    [No Abstract]   [Full Text] [Related]  

  • 16. Male breast cancer incidence among atomic bomb survivors.
    Ron E; Ikeda T; Preston DL; Tokuoka S
    J Natl Cancer Inst; 2005 Apr; 97(8):603-5. PubMed ID: 15840883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumors of the major and minor salivary glands: review of 25 years of experience.
    Nagler RM; Laufer D
    Anticancer Res; 1997; 17(1B):701-7. PubMed ID: 9066605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparisons of lung tumour mortality risk in the Japanese A-bomb survivors and in the Colorado Plateau uranium miners: support for the ICRP lung model.
    Little MP
    Int J Radiat Biol; 2002 Mar; 78(3):145-63. PubMed ID: 11869470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absence of evidence for differences in the dose-response for cancer and non-cancer endpoints by acute injury status in the Japanese atomic-bomb survivors.
    Little MP
    Int J Radiat Biol; 2002 Nov; 78(11):1001-10. PubMed ID: 12456287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer mortality among atomic bomb survivors exposed in utero or as young children, October 1950-May 1992.
    Delongchamp RR; Mabuchi K; Yoshimoto Y; Preston DL
    Radiat Res; 1997 Mar; 147(3):385-95. PubMed ID: 9052687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.